Literature DB >> 30851829

Minimally Invasive Colon Cancer Surgery.

Katerina O Wells1, Anthony Senagore2.   

Abstract

Colon cancer is the second leading cause of cancer death in the United States. Advances in surgical resection techniques, including minimally invasive colectomy, are becoming a standard of care. The oncologic principles of colectomy have included adequate lymphadenectomy, proximal ligation of primary vessels, and resection with adequate longitudinal margins. More recently, complete mesocolic excision has been advocated. Open and minimally invasive approaches must accomplish the same outcomes. This article focuses on the surgical principles of colon cancer, perioperative considerations, and technical aspects of minimally invasive colectomy. We review the current literature regarding oncologic and short-term outcomes of minimally invasive surgery.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colectomy; Colon cancer; Laparoscopy; Minimally invasive; Outcomes; Robotics; Surgical management

Mesh:

Year:  2018        PMID: 30851829     DOI: 10.1016/j.soc.2018.11.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  7 in total

1.  The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology.

Authors:  Aldo Rocca; Federica Cipriani; Paolo Delrio; Fulvio Calise; Luca Aldrighetti; Giulio Belli; Stefano Berti; Ugo Boggi; Vincenzo Bottino; Umberto Cillo; Matteo Cescon; Matteo Cimino; Francesco Corcione; Luciano De Carlis; Maurizio Degiuli; Paolo De Paolis; Agostino Maria De Rose; Domenico D'Ugo; Fabrizio Di Benedetto; Ugo Elmore; Giorgio Ercolani; Giuseppe M Ettorre; Alessandro Ferrero; Marco Filauro; Felice Giuliante; Salvatore Gruttadauria; Alfredo Guglielmi; Francesco Izzo; Elio Jovine; Andrea Laurenzi; Francesco Marchegiani; Pierluigi Marini; Marco Massani; Vincenzo Mazzaferro; Michela Mineccia; Francesco Minni; Andrea Muratore; Simone Nicosia; Riccardo Pellicci; Riccardo Rosati; Nadia Russolillo; Antonino Spinelli; Gaya Spolverato; Guido Torzilli; Giovanni Vennarecci; Luca Viganò; Leonardo Vincenti
Journal:  Updates Surg       Date:  2021-06-05

2.  LINC00630 as a miR-409-3p sponge promotes apoptosis and glycolysis of colon carcinoma cells via regulating HK2.

Authors:  Jian Chen; Runjie Wang; Enci Lu; Shan'ai Song; Yingwei Zhu
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

3.  Laparoscopy in the coronavirus disease 2019 (COVID-19) era.

Authors:  Stefano Angioni
Journal:  Gynecol Surg       Date:  2020-05-14

4.  Comparison of postoperative recovery of patients who underwent laparoscopic-assisted radical resection of right colon cancer with modified triangular anastomosis or tubular anastomosis: a retrospective cohort study.

Authors:  Tianfang Xia; Zhenguo Pan; Jie Zhang; Guo Xu
Journal:  BMC Surg       Date:  2021-02-10       Impact factor: 2.102

5.  Expression of Long Nonencoding Ribonucleic Acid SNHG20 in Colon Cancer Tissue in Its Influences on Chemotherapeutic Sensitivity of Colon Cancer Cells.

Authors:  Wenbin Cao; Bo Zhang; Yang Liu
Journal:  Biomed Res Int       Date:  2022-07-23       Impact factor: 3.246

6.  Comparison of open, laparoscopic, and robotic left colectomy for radical treatment of colon cancer: a retrospective analysis in a consecutive series of 211 patients.

Authors:  Zhixiang Huang; Taiyuan Li; Genghua Zhang; Zhen Zhou; Haoran Shi; Cheng Tang; Lingling Yang; Xiong Lei
Journal:  World J Surg Oncol       Date:  2022-10-18       Impact factor: 3.253

7.  Automated non-invasive identification of pelvic autonomic nerves with a handheld Raman spectrometer and potential application to nerve-sparing colorectal surgery: a preliminary study in surgical specimens.

Authors:  Sumito Sato; Hirotada Kagoshima; Manabu Shiozawa; Suguru Nukada; Kenta Iguchi; Yo Mikayama; Takashi Oshima; Masakatsu Numata; Hiroshi Tamagawa; Yasushi Rino; Munetaka Masuda; Kuniya Tanaka
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.